Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: OVR046
MIFTS: 52

Ovarian Cyst

Categories: Cancer diseases, Endocrine diseases, Reproductive diseases
Genes Variations Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Ovarian Cyst

About this section

MalaCards integrated aliases for Ovarian Cyst:

Name: Ovarian Cyst 12 30 6 15
Ovarian Cysts 56 44 45 74

Classifications:

MalaCards categories:
Global: Cancer diseases
Anatomical: Endocrine diseases Reproductive diseases
See all MalaCards categories (disease lists)
ICD10: 34


External Ids:

Disease Ontology 12 DOID:5119
ICD9CM 36 620.2
MeSH 45 D010048
ICD10 34 N83.2
Sources

Summaries for Ovarian Cyst

About this section
MedlinePlus : 44 The ovaries are part of the female reproductive system. They produce a woman's eggs and make female hormones. Ovarian cysts are fluid-filled sacs in or on an ovary. They usually form during ovulation, when the ovary releases an egg. They are usually harmless and go away by themselves. Most women have them sometime during their lives. Most ovarian cysts are small and don't cause symptoms. Women may not find out that they have them until they have a pelvic exam. If there are symptoms, they may include Pressure Bloating Swelling Pain in the lower abdomen, on the side where the cyst is If your health care provider finds a cyst, you may be able to wait to see if it gets bigger. You may need surgery if you have pain, are past menopause, or if the cyst does not go away. If a cyst bursts or causes bleeding, you should get medical help right away. Birth control pills can help prevent new cysts. Rarely, ovarian cysts can become cancerous. This risk increases as you get older. A health problem that involves ovarian cysts is polycystic ovary syndrome (PCOS). Women with PCOS can have high levels of male hormones, irregular or no periods, and small ovarian cysts. Dept. of Health and Human Services Office on Women's Health

MalaCards based summary : Ovarian Cyst, also known as ovarian cysts, is related to corpus luteum cyst and ovarian disease, and has symptoms including pelvic pain An important gene associated with Ovarian Cyst is MUC16 (Mucin 16, Cell Surface Associated), and among its related pathways/superpathways are Endochondral Ossification and Cell adhesion_Plasmin signaling. The drugs Drospirenone and Cyproterone Acetate have been mentioned in the context of this disorder. Affiliated tissues include ovary, breast and liver, and related phenotypes are endocrine/exocrine gland and liver/biliary system

Disease Ontology : 12 An ovarian disease that is characterized by the presence of a fluid-filled sac and is located in the ovary.

Wikipedia : 77 An ovarian cyst is a fluid-filled sac within the ovary. Often they cause no symptoms. Occasionally they... more...

Sources

Related Diseases for Ovarian Cyst

About this section

Diseases in the Ovarian Cyst family:

Malignant Ovarian Cyst

Diseases related to Ovarian Cyst via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 152)
# Related Disease Score Top Affiliating Genes
1 corpus luteum cyst 32.0 AFP FOXL2 MUC16
2 ovarian disease 31.2 FOXL2 MUC16 NOBOX PRL VEGFA
3 cystadenocarcinoma 29.8 MUC16 VEGFA
4 adenomyosis 29.7 PRL VEGFA
5 ovarian cancer 29.5 GSTP1 MUC16 PLAU VEGFA
6 neonatal ovarian cyst 12.3
7 malignant ovarian cyst 12.3
8 mccune-albright syndrome 11.4
9 fraser-like syndrome 11.1
10 aromatase deficiency 11.1
11 bleeding disorder, platelet-type, 19 11.1
12 autoimmune oophoritis 11.1
13 lipedematous scalp 11.1
14 opisthorchiasis 10.3 AFP MUC16
15 adenomatoid tumor 10.3 AFP MUC16
16 breast cancer 10.3
17 endodermal sinus tumor 10.3 AFP MUC16
18 testicular granulosa cell tumor 10.3 AFP FOXL2
19 juvenile type testicular granulosa cell tumor 10.3 AFP FOXL2
20 male reproductive organ benign neoplasm 10.3 AFP FOXL2
21 hydrocele 10.3 AFP VEGFA
22 peliosis hepatis 10.3 AFP VEGFA
23 primary peritoneal carcinoma 10.3 MUC16 VEGFA
24 telangiectasis 10.3 AFP VEGFA
25 vein disease 10.2 AFP VEGFA
26 hypothyroidism 10.2
27 pericardial effusion 10.2 MUC16 VEGFA
28 intratubular embryonal carcinoma 10.2 AFP PLAU
29 sex cord-gonadal stromal tumor 10.2 AFP FOXL2
30 serous cystadenocarcinoma 10.2 MUC16 VEGFA
31 placental insufficiency 10.2 AFP VEGFA
32 endometriosis 10.2
33 bile duct disease 10.2 AFP SLC25A13
34 lipodermatosclerosis 10.2 SERPINB2 VEGFA
35 uterine anomalies 10.2 AFP VEGFA
36 ovarian brenner tumor 10.2 MUC16 PRL
37 biliary tract disease 10.1 AFP SLC25A13
38 granulosa cell tumor of the ovary 10.1 FOXL2 PRL
39 hyperphenylalaninemia, bh4-deficient, a 10.1 PRL SLC25A13
40 pituitary tumors 10.1 PRL VEGFA
41 meningocele 10.1
42 ectopic pregnancy 10.1
43 joint disorders 10.1 PLAU SERPINB2
44 ovarian hyperstimulation syndrome 10.0
45 adenoma 10.0
46 hydronephrosis 10.0
47 leiomyoma 10.0
48 intestinal obstruction 10.0
49 female reproductive system disease 10.0 FOXL2 PRL VEGFA
50 pre-eclampsia 10.0 AFP SERPINB2 VEGFA

Graphical network of the top 20 diseases related to Ovarian Cyst:



Diseases related to Ovarian Cyst
Sources

Symptoms & Phenotypes for Ovarian Cyst

About this section

UMLS symptoms related to Ovarian Cyst:


pelvic pain

MGI Mouse Phenotypes related to Ovarian Cyst:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 endocrine/exocrine gland MP:0005379 9.73 AFP FOXL2 NOBOX PLAU PRL VEGFA
2 liver/biliary system MP:0005370 9.55 AFP PLAU PRL SLC25A13 VEGFA
3 neoplasm MP:0002006 9.35 AFP PLAU PRL SERPINB2 VEGFA
4 reproductive system MP:0005389 9.1 AFP FOXL2 NOBOX PLAU PRL VEGFA
Sources

Drugs & Therapeutics for Ovarian Cyst

About this section

Drugs for Ovarian Cyst (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 389)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Drospirenone Approved Phase 4,Phase 3,Phase 1,Not Applicable 67392-87-4 68873
2
Cyproterone Acetate Approved, Investigational Phase 4,Phase 2,Phase 3,Early Phase 1,Not Applicable 427-51-0
3
Polyestradiol phosphate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 28014-46-2
4
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-28-2 5757
5
Ethinyl Estradiol Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 57-63-6 5991
6
Metformin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 657-24-9 14219 4091
7
Resveratrol Approved, Experimental, Investigational Phase 4,Phase 1,Not Applicable 501-36-0 445154
8
Simvastatin Approved Phase 4,Phase 3,Not Applicable 79902-63-9 54454
9
Ganirelix Approved Phase 4,Early Phase 1 123246-29-7, 124904-93-4 25081094
10
Sodium Citrate Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 68-04-2
11
Orlistat Approved, Investigational Phase 4,Phase 2 96829-58-2 3034010
12
Letrozole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 112809-51-5 3902
13
Pioglitazone Approved, Investigational Phase 4,Not Applicable,Early Phase 1 111025-46-8 4829
14
leucovorin Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 58-05-9 6006 143
15
Acarbose Approved, Investigational Phase 4,Not Applicable 56180-94-0 441184
16
Zinc Approved, Investigational Phase 4,Early Phase 1,Not Applicable 7440-66-6 32051
17
Progesterone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 57-83-0 5994
18
Hydrocortisone Approved, Vet_approved Phase 4,Not Applicable,Early Phase 1 50-23-7 5754
19
Hydrocortisone acetate Approved, Vet_approved Phase 4,Not Applicable,Early Phase 1 50-03-3
20
Glucagon Approved Phase 4,Phase 3,Not Applicable 16941-32-5
21
Testosterone Approved, Experimental, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 58-22-0, 481-30-1 6013 10204
22
Danazol Approved Phase 4 17230-88-5 28417
23
Etoricoxib Approved, Investigational Phase 4 202409-33-4 123619
24
Liraglutide Approved Phase 4,Phase 3 204656-20-2 44147092
25
Menotropins Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 9002-68-0, 61489-71-2 5360545
26
Acetylcysteine Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 616-91-1 12035
27
Citalopram Approved Phase 4 59729-33-8 2771
28
Racepinephrine Approved Phase 4,Not Applicable,Early Phase 1 329-65-7 838
29
Epinephrine Approved, Vet_approved Phase 4,Not Applicable,Early Phase 1 51-43-4 5816
30
Alogliptin Approved Phase 4 850649-61-5 11450633
31
Moxonidine Approved, Investigational Phase 4 75438-57-2 4810
32
Nicotinamide Approved, Investigational Phase 4 98-92-0 936
33
Methylcobalamin Approved, Experimental, Investigational Phase 4,Not Applicable 13422-55-4
34
Hydroxocobalamin Approved Phase 4,Not Applicable 13422-51-0 11953898 15589840
35
Leuprolide Approved, Investigational Phase 4,Phase 2,Not Applicable,Early Phase 1 53714-56-0 657181 3911
36
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 1,Phase 2 9004-61-9 53477741
37
Rosiglitazone Approved, Investigational Phase 4,Not Applicable 122320-73-4 77999
38
Exenatide Approved, Investigational Phase 4,Phase 3,Phase 2 141758-74-9 15991534
39
Tamoxifen Approved Phase 4,Phase 3 10540-29-1 2733526
40
Benzocaine Approved, Investigational Phase 4,Phase 2,Not Applicable,Early Phase 1 94-09-7, 1994-09-7 2337
41
tannic acid Approved Phase 4,Phase 2,Not Applicable,Early Phase 1 1401-55-4
42
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable,Early Phase 1 50-02-2 5743
43
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable,Early Phase 1 1177-87-3
44
Medroxyprogesterone acetate Approved, Investigational Phase 4,Not Applicable 71-58-9
45
Desogestrel Approved Phase 4,Phase 3 54024-22-5 40973
46
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
47
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
48
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
49
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
50
Toremifene Approved, Investigational Phase 4 89778-26-7 3005573

Interventional clinical trials:

(show top 50) (show all 598)
# Name Status NCT ID Phase Drugs
1 The Impact on Ovarian Reserve After Single-port, Two-port, or Four-port Access Laparoscopic Ovarian Cyst Enucleation Unknown status NCT01631253 Phase 4
2 Trial Comparing hCG Triggering Versus GnRH Agonist Triggering in PCOS Patients Unknown status NCT01683513 Phase 4 GnRh agonist +1500E hCG
3 Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants Unknown status NCT02027337 Phase 4 20 mcg ethinylestradiol /3 mg drospirenone;20 mcg ethinylestradiol/3 mg drospirenone and Selmevit;30 mcg ethinylestradiol/3 mg drospirenone;30 mcg ethinylestradiol/3 mg drospirenone and Selmevit;35 mcg ethinylestradiol/2 mg cyproterone;35 mcg ethinylestradiol/2 mg cyproterone and Selmevit
4 Myoinositol for the Treatment of Ovarian and Psychiatric Disorder in Polycystic Ovary Syndrome (PCOS) Patients Unknown status NCT01246310 Phase 4
5 Metformin in Infertile PCOS Patients Unknown status NCT00501904 Phase 4 Metformin
6 the Effect of Diane-35 Pretreatment on In-vitro Fertilization Outcome for Patients With Polycystic Ovary Syndrome Unknown status NCT01752270 Phase 4 Diane-35 pretreatment;Diane-35 pretreatment
7 Effects of Simvastatin and Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients Unknown status NCT02766803 Phase 4 Simvastatin and micronized trans-resveratrol
8 Therapeutic Monitoring of Metformin in Women With Polycystic Ovary Syndrome Unknown status NCT01366391 Phase 4 Metformin
9 Endometrial Scratching During Laproscopic Ovarian Drilling in Subfertile PCOS Women Unknown status NCT02140398 Phase 4
10 Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients Unknown status NCT00417144 Phase 4 Arvekap 0.1mg (Triptorelin, Ipsen, France);Ganirelix 0.25mg (Orgalutran, Organon, The Netherlands)
11 Surgical Ovarian Drilling Versus Hormonal Treatment for Infertility Associated to PolyCystic Ovaries Syndrome (PCOS) Unknown status NCT00378729 Phase 4 Metformin and FSHr
12 Metformin and Gestational Diabetes in High-risk Patients: a RCTs Unknown status NCT00883259 Phase 4 Metformin
13 The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS) Unknown status NCT01475019 Phase 4 Orlistat;Sibutramine
14 Strategies for Ovulation Induction in Anovulatory Infertile Patients With PCOS Unknown status NCT00461643 Phase 4 Clomiphene citrate, metformin, metformin plus clomiphene citrate, gonadotropins
15 The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cyst Completed NCT00713778 Phase 4
16 A Random Clinical Trial (RCT) of the Impact of Electrocoagulation on Ovarian Reserve Completed NCT00746278 Phase 4
17 Clinical Evaluation of Furocyst in Patients With Poly Cystic Ovary Syndrome Completed NCT02789488 Phase 4
18 The Role of Estrogen in Luteinizing Hormone Surge and Ovulation Completed NCT01999569 Phase 4 Letrozole
19 Danazol Treatment in Endometriosis Women Before IVF Completed NCT01779232 Phase 4 Danazol;placebo
20 Pain Post Abdominal Laparoscopy Prevention With Arcoxia Completed NCT00565682 Phase 4 etoricoxib 120 mg
21 FSH/LH Ratio as a Predictor of IVF Outcome in Young and Older Women Completed NCT02674178 Phase 4
22 Effects of Metformin Plus Simvastatin on Polycystic Ovarian Syndrome (PCOS): A Prospective, Randomized, Double-Blind, Placebo-Controlled Study Completed NCT01021579 Phase 4 Metformin plus Placebo;Metfomin plus Simvastatin
23 The Effect of Ethinyl Estradiol on Polycystic Ovary Syndrome Women Undergoing Intrauterine Insemination Completed NCT01219101 Phase 4 clomiphene citrate with ethinyl esteradiol;clomiphene citrate with plasebo
24 Vitamin D Increases Serum Levels of the Soluble Receptor for Advanced Glycation End Products in Women With PCOS Completed NCT03644212 Phase 4 Vitamin D3
25 Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary Syndrome Completed NCT03122041 Phase 4 Sitagliptin
26 Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss Completed NCT02941445 Phase 4 sitagliptin and metformin;Metformin
27 The Effect of Metformin on Different Hormones in PCOS Patients Completed NCT02568488 Phase 4 Metformin
28 Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome Completed NCT02483299 Phase 4 Metformin;Glucophage tablets and Victoza
29 Phytoestrogens as an Alternative to Estradiol in Ovulation Induction in PCOS Completed NCT02352597 Phase 4 phytoestrogen;estradiol valerate;clomiphene citrate
30 PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome Completed NCT02187250 Phase 4 metformin;liraglutide;roflumilast
31 PDE-4 Inhibitor Roflumilast and Polycystic Ovary Syndrome Completed NCT02037672 Phase 4 metformin;metformin and roflumilast
32 Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin Completed NCT01911468 Phase 4 metformin;liraglutide;metformin and liraglutide
33 Polycystic Ovary Syndrome and Liraglutide Completed NCT01899430 Phase 4 liraglutide;metformin
34 Vitamin D Treatment, Pharmacogenetics and Glucose Metabolism Completed NCT01721915 Phase 4 Vitamin D supplementation;Placebo
35 Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican Women Completed NCT01675310 Phase 4 medical nutrition therapy + metformin
36 hMG or Recombinant FSH on OHSS Prevention in PCOS Patients Undergoing IVF Completed NCT01365936 Phase 4 HMG;rFSH
37 Adding L-Carnitine to Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovary Syndrome Completed NCT03630341 Phase 4 Clomiphene Citrate 50mg;L-carnitine;Placebo Oral Tablet
38 The Effect of a Liraglutide on IVF in Obese PCOS Completed NCT03353948 Phase 4 MET;COMBI
39 Oral Contraceptive and Cardiovascular Risk in PCOS Completed NCT00593294 Phase 4 OC - Drospirenone plus Ethynylestradiol
40 The Effects of OCP and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in PCOS Completed NCT02866786 Phase 4 Metformin;ethinyl estradiol and cyproterone acetate
41 Metformin and Oral Contraceptives in PCOS Completed NCT00451568 Phase 4 Metformin;Desorelle
42 The Effects of Vitamin D on Angiogenic Factors in Women With Polycystic Ovary Syndrome Completed NCT02460380 Phase 4 Vitamin D3
43 Trial With Metformin in Women With Polycystic Ovary Syndrome Completed NCT02280057 Phase 4 Metformin;Placebo
44 N-acetyl Cysteine for Ovulation Induction in Clomiphene Citrate Resistant Polycystic Ovary Syndrome Completed NCT02239107 Phase 4 N-Acetyl cysteine
45 LIPT - Liraglutide in Polycystic Ovary Syndrome Completed NCT02073929 Phase 4 Liraglutide for 26 weeks;placebo
46 The Effect of Cipralex on Quality of Life, Adrenal Activity Glucose Metabolism, Physical and Mental Health in PCOS Completed NCT01961180 Phase 4 Cipralex;Placebo
47 Comparison of Alogliptin Versus Alogliptin and Pioglitazone on Insulin Resistance of Metformin Treated Women With PCOS Completed NCT02683226 Phase 4 Vipdomet;Incresync
48 Role of Melatonin Supplementation in Follicular Fluid of in Vitro Fertilization (IVF) Patients With Polycystic Ovarian Syndrome Completed NCT01540747 Phase 4
49 Polycystic Ovary Syndrome - Improving Outcomes Completed NCT01504321 Phase 4 Moxonidine;Placebo
50 Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism Completed NCT01360996 Phase 4 3 mg DRSP/20 μg EE

Search NIH Clinical Center for Ovarian Cyst

Cochrane evidence based reviews: ovarian cysts

Sources

Genetic Tests for Ovarian Cyst

About this section

Genetic tests related to Ovarian Cyst:

# Genetic test Affiliating Genes
1 Ovarian Cyst 30
Sources

Anatomical Context for Ovarian Cyst

About this section

MalaCards organs/tissues related to Ovarian Cyst:

42
Ovary, Breast, Liver, Bone, Brain, Prostate, Heart

The Foundational Model of Anatomy Ontology organs/tissues related to Ovarian Cyst:

20
The Ovary
Sources

Publications for Ovarian Cyst

About this section

Articles related to Ovarian Cyst:

(show top 50) (show all 1375)
# Title Authors Year
1
Remission of diabetes mellitus after ovariohysterectomy in a guinea pig with ovarian cysts. ( 30808039 )
2019
2
SERS-based detection of haptoglobin in ovarian cyst fluid as a point-of-care diagnostic assay for epithelial ovarian cancer. ( 30774440 )
2019
3
Suggestive hypothesis on a case report: Patient presenting with cyclical ovarian cysts coupled to increased cholestatic enzymes. ( 30393940 )
2019
4
Hyperreactio Luteinalis: large bilateral ovarian cysts during pregnancy. ( 30807861 )
2019
5
The prognostic value of antenatal ultrasound in cases complicated by fetal ovarian cysts. ( 30883366 )
2019
6
The effects of sclerotherapy with 5% trichloroacetic acid on the cyst diameter and ovarian tissue in the rat ovarian cyst model. ( 29564948 )
2018
7
Vaginal bleeding and a giant ovarian cyst in an infant with 21-hydroxylase deficiency. ( 29252197 )
2018
8
Omental fat necrosis without torsion mimicking ovarian cyst torsion. ( 29685724 )
2018
9
Ovarian cyst removal influences ovarian reserve dependent on histology, size and type of operation. ( 29806554 )
2018
10
A Giant Ovarian Cyst in an Adolescent. ( 29731358 )
2018
11
High Frequency of Ovarian Cyst Development in Vhl<sup>2B/+</sup>;Snf5<sup>+/-</sup> Mice. ( 29684361 )
2018
12
Successful treatment of a giant ovarian cyst by levothyroxin in a young adult woman: A case report. ( 30051551 )
2018
13
The effect of tamoxifen therapy on the endometrium and ovarian cyst formation in patients with breast cancer. ( 30254998 )
2018
14
Histological classification of canine ovarian cyst types with reference to medical history. ( 30304884 )
2018
15
Fishnet/cobweb ovary: Haemorrhagic ovarian cyst. ( 30309168 )
2018
16
High Incidence of Ovarian Cysts in Women Receiving mTOR Inhibitors After Renal Transplantation. ( 29087803 )
2018
17
Daughter cyst sign in ovarian cysts. ( 29198005 )
2018
18
In-utero aspiration vs expectant management of anechoic fetal ovarian cysts: open randomized controlled trial. ( 29205608 )
2018
19
A retrospective multicenter study of the natural history of fetal ovarian cysts. ( 29534823 )
2018
20
Anti-Müllerian hormone levels and spontaneous pregnancy in women undergoing surgery for benign ovarian cysts. ( 29724140 )
2018
21
Variation in Downstream Relative Costs Associated With Incidental Ovarian Cysts on Ultrasound. ( 29728324 )
2018
22
Diagnostic value of neutrophil to lymphocyte ratio in differentiation of ruptured ovarian cysts and adnexal torsion. ( 29971185 )
2018
23
Re: In-utero aspiration vs expectant management of anechoic fetal ovarian cysts: open randomized controlled trial. C. Diguisto , N. Winer , G. Benoist , H. Laurichesse-Delmas , J. Potin , A. Binet , H. Lardy , B. Morel and F. Perrotin . Ultrasound Obstet Gynecol 2018; 52: 159-164. ( 30095235 )
2018
24
The Evaluation of Laparoscopic Surgery on Pregnant Patients with Ovarian Cysts and Its Effects on Pregnancy over the Past 5 Years. ( 30254926 )
2018
25
How long should we follow simple ovarian cysts with pelvic ultrasonography? ( 30289754 )
2018
26
Assessment of Diagnostic Values among CA-125, RMI, HE4, and ROMA for Cancer Prediction in Women with Nonfunctional Ovarian Cysts. ( 30402106 )
2018
27
Impending abdominal compartment syndrome from a giant ovarian cyst torsion. ( 28922702 )
2017
28
Case Report of Clitoral Hypertrophy in 2 Extremely Premature Girls With an Ovarian Cyst. ( 28931575 )
2017
29
Performance of ovarian cyst fluid fine-needle aspiration cytology. ( 28834408 )
2017
30
Haemoperitoneum due to ruptured ovarian cyst in a 13-year-old girl with factor V deficiency- A case report. ( 28138193 )
2017
31
Laparoscopic Management of a Giant Ovarian Cyst in a Premenarchal Girl. ( 28104495 )
2017
32
A Wandering Abdominal Mass in a Neonate: An Enteric Duplication Cyst Mimicking an Ovarian Cyst. ( 28348910 )
2017
33
Diagnostic accuracy of haptoglobin within ovarian cyst fluid as a potential point-of-care test for epithelial ovarian cancer: an observational study. ( 28755436 )
2017
34
Complete Laparoscopic Extirpation of a Giant Ovarian Cyst in an Adolescent. ( 28840047 )
2017
35
Presacral mass in the setting of an ovarian cyst and abdominal pain. ( 28659365 )
2017
36
Enormous Ovarian Cyst. ( 29021455 )
2017
37
Giant ovarian cyst masquerading as a massive ascites: a case report. ( 29258579 )
2017
38
Hemorrhage in a Fetal Ovarian Cyst. ( 28770146 )
2017
39
Treatment of Recurrent Ovarian Cysts and Primary Infertility by Iranian Traditional Medicine: A Case Report. ( 27932523 )
2017
40
Outcome of fetal ovarian cysts diagnosed on prenatal ultrasound examination: systematic review and meta-analysis. ( 27325566 )
2017
41
The relationship between functional ovarian cysts and vitamin A, vitamin E, and folate intake. ( 27924658 )
2017
42
Neonatal ovarian cysts: ultrasound assessment and differential diagnosis. ( 28024877 )
2017
43
Age-Specific Frequencies and Characteristics of Ovarian Cysts in Children and Adolescents. ( 28044991 )
2017
44
Management of Complex Ovarian Cysts in Newborns - Our Experience. ( 28083489 )
2017
45
Evaluation and Treatment Results of Ovarian Cysts in Childhood and Adolescence: A Multicenter, Retrospective Study of 100 Patients. ( 28167139 )
2017
46
The Diagnosis and Management of Ovarian Cysts in Children. ( 28214196 )
2017
47
Bilateral Ovarian Torsion during Follow-up for Antenatally Detected Ovarian Cysts. ( 28540192 )
2017
48
Effect of menstrual phase on the surgical treatment of ovarian cysts. ( 28597715 )
2017
49
Comparative Gene Expression Analysis of Lymphocytes Treated with Exosomes Derived from Ovarian Cancer and Ovarian Cysts. ( 28620375 )
2017
50
Microarray analysis reveals differentially expressed lncRNAs in benign epithelial ovarian cysts and normal ovaries. ( 28656240 )
2017
Sources

Variations for Ovarian Cyst

About this section

ClinVar genetic disease variations for Ovarian Cyst:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 46;XX;ins(5;6)(p13;p24p25)dn Translocation Pathogenic
Sources

Expression for Ovarian Cyst

About this section
Search GEO for disease gene expression data for Ovarian Cyst.
Sources

Pathways for Ovarian Cyst

About this section

Pathways related to Ovarian Cyst according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Endochondral Ossification 1
10.97 PLAU VEGFA
2
Cell adhesion_Plasmin signaling 23
10.65 PLAU VEGFA
3
Dissolution of Fibrin Clot 67
9.74 PLAU SERPINB2
Sources

GO Terms for Ovarian Cyst

About this section

Cellular components related to Ovarian Cyst according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.5 AFP GSTP1 MUC16 PLAU PRL SERPINB2
2 extracellular space GO:0005615 9.17 AFP GSTP1 MUC16 PLAU PRL SERPINB2

Biological processes related to Ovarian Cyst according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 response to nutrient levels GO:0031667 9.26 GSTP1 PRL
2 lactation GO:0007595 9.16 PRL VEGFA
3 positive regulation of epithelial cell proliferation GO:0050679 9.02 VEGFA
4 ovarian follicle development GO:0001541 8.96 FOXL2 VEGFA
5 fibrinolysis GO:0042730 8.62 PLAU SERPINB2
Sources

Sources for Ovarian Cyst

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....